An interventional trial of ENALAPRIL MALEATE for PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME
Phase 1
- Conditions
- Health Condition 1: N979- Female infertility, unspecified
- Registration Number
- CTRI/2020/06/026143
- Lead Sponsor
- Office of DGAFMS MoD GOI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
(i)Women with PCOS undergoing assisted conception, having more than 4 follicles at the time of hCG or LH trigger
(ii)Women undergoing assisted conception, expected to have more than 16 oocytes retrieval.
(iii)Women with known PCOS, both lean and obese.
(iv)Women with previous history of OHSS
(v)High responders
(vi)Women with S.estradiol levels > 5000pg/ml, on the day of trigger
Exclusion Criteria
Exclusion criteria would include women with androgen secreting tumors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevention of OHSSTimepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method ILTimepoint: NOT APPLICABLE